Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Roles of Eph Receptors, Neuropilin-1, P2x7, and Cd147 in Covid-19-Associated Neurodegenerative Diseases: Inflammasome and Jak Inhibitors As Potential Promising Therapies Publisher Pubmed



Zalpoor H1, 2, 3 ; Akbari A4 ; Samei A5 ; Forghaniesfidvajani R4 ; Kamali M6 ; Afzalnia A6 ; Manshouri S6 ; Heidari F7 ; Pornour M8 ; Khoshmirsafa M9 ; Aazami H10 ; Seif F2, 11
Authors

Source: Cellular and Molecular Biology Letters Published:2022


Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic has spread worldwide, and finding a safe therapeutic strategy and effective vaccine is critical to overcoming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, elucidation of pathogenesis mechanisms, especially entry routes of SARS-CoV-2 may help propose antiviral drugs and novel vaccines. Several receptors have been demonstrated for the interaction of spike (S) protein of SARS-CoV-2 with host cells, including angiotensin-converting enzyme (ACE2), ephrin ligands and Eph receptors, neuropilin 1 (NRP-1), P2X7, and CD147. The expression of these entry receptors in the central nervous system (CNS) may make the CNS prone to SARS-CoV-2 invasion, leading to neurodegenerative diseases. The present review provides potential pathological mechanisms of SARS-CoV-2 infection in the CNS, including entry receptors and cytokines involved in neuroinflammatory conditions. Moreover, it explains several neurodegenerative disorders associated with COVID-19. Finally, we suggest inflammasome and JaK inhibitors as potential therapeutic strategies for neurodegenerative diseases. © 2022, The Author(s).
Other Related Docs
11. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
12. The Role of Sars-Cov-2 Accessory Proteins in Immune Evasion, Biomedicine and Pharmacotherapy (2022)
16. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)